Advertisement

Orchard Therapeutics plc ORTX

Set alert

Price alert · ORTX

All alert types
16.70 +16.70 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
380.11M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-3.35
Beta
0.55
Short ratio
0.28
Inst. own
103.60%
Dividend
0.00
Ex-div date
Earnings
Mar 4, 2024
50-d avg
16.44
200-d avg
10.11
1y target
16.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ORTX has not been loaded yet. Try again in a moment.

Revenue & Expenses

Revenue by
Product → Revenue: $5.56MRevenue → Gross Profit: $4.56MGross Profit → Expenses: $4.56MRevenue → Cost of Revenue: $1.75MExpenses → Selling, General & Admin: $11.61MExpenses → Research & Development: $14.55MExpenses → Interest Expense: $932.00KExpenses → Other Expenses: $11.81MExpenses → Income Tax: $976.00KNet Loss → Expenses: $35.32MCollaboration → Revenue: $743.00KGross Profit$4.56MNet Loss$35.32MCost of Revenue$1.75MExpenses$39.88MSelling, General & Admin$11.61MResearch & Development$14.55MInterest Expense$932.00KOther Expenses$11.81MIncome Tax$976.00KRevenue$6.30MProduct$5.56MCollaboration$743.00K

Period ending Sep 30, 2023 · select a line to chart its history

Income statement

ORTX quarterly income statement
6.30M
6.30M
1.75M
4.56M
26.16M
14.55M
11.61M
-21.61M
932.00K
976.00K
-35.32M
-35.32M
-35.32M
-35.32M
-1.50
-1.50
-1.50
-33.41M
-33.41M
228.39M
228.39M

Balance sheet

ORTX quarterly balance sheet
23.47M
23.47M
106.16M
101.94M
4.21M
6.19M
153.92M
27.13M
202.27M
14.98M
47.82M
49.38M
32.84M
122.01M
-965.92M
22.61M
80.26M
80.26M
48.34M
47.82M
11.09M
3.32M
6.64M
72.63M
3.66M
11.61M

Cash flow

ORTX quarterly cash flow
652.00K
-2.35M
-14.80M
-126.00K
18.00K
-2.36M
11.58M
11.71M
-23.89M
-141.00K
2.47M
Advertisement